Gallbladder cancer during pregnancy treated with surgery and adjuvant gemcitabine: A case report and review of the literature

Gallbladder cancer during pregnancy treated with surgery and adjuvant gemcitabine: A case report and review of the literature

BackgroundGallbladder cancer (GBC) represents the most common biliary tract cancer. Prognosis remains poor with 5-year overall survival rates less than 5% in advanced stages. GBCs are diagnosed more frequently in women, supposedly due to endocrine factors.CaseA 35-year-old woman, diagnosed with a no...

Full description

Bibliographic Details
Main Authors:	A. Diciolla, M. Gianoni, M. Fleury, P. Szturz, N. Demartines, S. Peters, R. Duran, D. Desseauve, Monnat A. Panchaud, F. Fasquelle, A. Digklia
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Series:	Frontiers in Oncology
Subjects:	gallbladder cancer chemotherapy pregnancy gemcitabin biliary tract cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1006387/full

Similar Items

Erratum: Gallbladder cancer during pregnancy treated with surgery and adjuvant gemcitabine: A case report and review of the literature
by: Frontiers Production Office
Published: (2023-03-01)

Case Report: Vasculitis Triggered by SIRT in a Patient With Previously Untreated Cholangiocarcinoma
by: Antonia Stamatiou, et al.
Published: (2021-12-01)

Role of Maintenance Gemcitabine in Advanced Carcinoma Gallbladder
by: Manish Sharma, et al.
Published: (2020-10-01)

Evaluation of abnormal gallbladder imaging findings: Surgical management and pathologic correlations in early‐stage gallbladder cancer
by: Ellen J. Spartz, et al.
Published: (2022-07-01)

Successful conversion surgery for locally advanced gallbladder cancer after gemcitabine and nab-paclitaxel chemotherapy
by: Ziyi Yang, et al.
Published: (2022-08-01)

Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study
by: Alexander R. Siebenhüner, et al.
Published: (2018-01-01)

HKI-272 contributes to gemcitabine-mediated anti-proliferative and anti-metastatic effects through EGFR suppression in gallbladder cancer
by: Xuli Yang, et al.
Published: (2022-12-01)

Early Relapse of Unresectable Gallbladder Cancer after Discontinuation of Gemcitabine Monotherapy Administered for 5 Years in a Patient Who Had Complete Response to the Treatment
by: Koichi Suyama, et al.
Published: (2013-10-01)

Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin
by: Min su You, et al.
Published: (2019-01-01)

Rhabdomyosarcoma of the gallbladder
by: Jingjing Yu, et al.
Published: (2022-07-01)

Gemcitabine and S-1 Combination Chemotherapy in Patients with Advanced Biliary Tract Cancer:A Retrospective Study
by: Kazuhito Mita, et al.
Published: (2010-12-01)

The Many Hidden Faces of Gallbladder Carcinoma on CT and MRI Imaging—From A to Z
by: Damaris Neculoiu, et al.
Published: (2024-02-01)

Conversion surgery following gemcitabine plus cisplatin therapy for initially unresectable gallbladder cancer with peritoneal carcinomatosis: a case report
by: Yusuke Wakasa, et al.
Published: (2022-03-01)

Targeting P53 as a Future Strategy to Overcome Gemcitabine Resistance in Biliary Tract Cancers
by: Chiao-En Wu, et al.
Published: (2020-10-01)

Synchronous primary gallbladder and pancreatic cancer associated with congenital biliary dilatation and pancreaticobiliary maljunction
by: Haruki Mori, et al.
Published: (2017-11-01)

Gallbladder cancer with EGFR mutation and its response to GemOx with erlotinib: a case report and review of literature
by: Kishan Soni, et al.
Published: (2020-07-01)

Effect of Rowachol on the Gallbladder Dysmotility Disorder Based on Gallbladder Ejection Fraction
by: Sang Hoon Lee, et al.
Published: (2023-01-01)

A Novel Gemcitabine-Resistant Gallbladder Cancer Model Provides Insights into Molecular Changes Occurring during Acquired Resistance
by: Luis Vergara-Gómez, et al.
Published: (2023-04-01)

BRAZILIAN CONSENSUS ON INCIDENTAL GALLBLADDER CARCINOMA
by: Felipe Jose F COIMBRA, et al.
Published: (2020-07-01)

Duplication of the Gallbladder: A Rare Congenital Anomaly
by: Madhusudhan KS, et al.
Published: (2018-07-01)

Establishment of a Pretreatment Nomogram to Predict the 6-Month Mortality Rate of Patients with Advanced Biliary Tract Cancers Undergoing Gemcitabine-Based Chemotherapy
by: Chiao-En Wu, et al.
Published: (2021-06-01)

Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world experience
by: Chiao-En Wu, et al.
Published: (2020-05-01)

ATM Inhibitor Suppresses Gemcitabine-Resistant BTC Growth in a Polymerase θ Deficiency-Dependent Manner
by: Yi-Ru Pan, et al.
Published: (2020-11-01)

Carcinoma of Gallbladder: Its Frequency and Clinical Presentations in two hundred cases of Cholelithiasis
by: Tahir Uddin Qazi, et al.
Published: (2013-07-01)

Gallbladder perforation presenting as a hepatic neoplasm
by: Sangara Narayanan, et al.
Published: (2016-06-01)

Unusual presentation of gallbladder papillomatosis without bile duct involvement: A case report
by: Amal Lahfidi, Dr., et al.
Published: (2021-06-01)

Pregnancy and gallbladder disease
by: Nahum Mendez-Sanchez, et al.
Published: (2006-07-01)

Multiseptate Gallbladder in a Patient with Biliary Dyskinesia
by: Michael Talalaev, et al.
Published: (2020-08-01)

Low frequency of mismatch repair deficiency in gallbladder cancer
by: Benjamin Goeppert, et al.
Published: (2019-05-01)

Gallbladder cancer mimicking perihilar cholangiocarcinoma—considerable rate of postoperative reclassification with implications for prognosis
by: Lynn E. Nooijen, et al.
Published: (2023-09-01)

Krukenberg Tumor Related to Gallbladder Cancer in a Young Woman: A Case Report and Review of the Literature
by: Giulia Grizzi, et al.
Published: (2023-06-01)

Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) – a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)– the AIO/ CALGP/ ACO- GAIN-trial –
by: Thorsten O. Goetze, et al.
Published: (2020-02-01)

The Utility of Gallbladder Absence on Ultrasound for Children With Biliary Atresia
by: Andrea Ho, et al.
Published: (2021-06-01)

Synergistic and Pharmacotherapeutic Effects of Gemcitabine and Cisplatin Combined Administration on Biliary Tract Cancer Cell Lines
by: Yasunari Sakamoto, et al.
Published: (2019-09-01)

Concurrent Chemoradiation With Weekly Gemcitabine and Cisplatin in Locally Advanced Cervical Cancer
by: Esmati E, et al.
Published: (2011-12-01)

Perforation of the gallbladder presenting as upper respiratory tract infection
by: Fran Matijević, et al.
Published: (2023-01-01)

Case report: From palliative to potentially curative – the advent of immunotherapy providing hope to advanced gallbladder adenocarcinoma
by: Eugene Kwong Fei Leong, et al.
Published: (2024-02-01)

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study
by: Monica Niger, et al.
Published: (2024-04-01)

Wee1 inhibition by MK1775 potentiates gemcitabine through accumulated replication stress leading to apoptosis in biliary tract cancer
by: Chiao-Ping Chen, et al.
Published: (2023-10-01)

Medical and surgical management of gallbladder sludge and mucocoele development in a Miniature Schnauzer
by: Harvey Saunders, et al.
Published: (2017-06-01)